{"id":"placebo-matching-rapastinel","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Somnolence"}]},"_chembl":{"chemblId":"CHEMBL3544917","moleculeType":"Protein","molecularWeight":"413.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Rapastinel acts as an allosteric modulator of the NMDA receptor, a key ionotropic glutamate receptor involved in synaptic plasticity and learning. By enhancing NMDA receptor-mediated neurotransmission, it is designed to improve cognitive deficits and potentially treat psychiatric disorders. The drug targets the glycine-binding site on the NMDA receptor to potentiate its activity.","oneSentence":"Rapastinel is an NMDA receptor modulator that enhances glutamatergic neurotransmission by potentiating NMDA receptor function to improve cognitive and psychiatric symptoms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:27:52.323Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder (as adjunctive treatment)"},{"name":"Cognitive impairment associated with schizophrenia"}]},"trialDetails":[{"nctId":"NCT03352453","phase":"PHASE2","title":"A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder","status":"TERMINATED","sponsor":"Naurex, Inc, an affiliate of Allergan plc","startDate":"2017-12-15","conditions":"Depressive Disorder, Major","enrollment":138},{"nctId":"NCT02951988","phase":"PHASE3","title":"A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder","status":"COMPLETED","sponsor":"Naurex, Inc, an affiliate of Allergan plc","startDate":"2016-11-13","conditions":"Depressive Disorder, Major","enrollment":1304},{"nctId":"NCT02943564","phase":"PHASE3","title":"A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)","status":"COMPLETED","sponsor":"Naurex, Inc, an affiliate of Allergan plc","startDate":"2016-11-01","conditions":"Depressive Disorder, Major","enrollment":658},{"nctId":"NCT02943577","phase":"PHASE3","title":"A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)","status":"COMPLETED","sponsor":"Naurex, Inc, an affiliate of Allergan plc","startDate":"2016-11-02","conditions":"Depressive Disorder, Major","enrollment":429},{"nctId":"NCT02932943","phase":"PHASE3","title":"A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)","status":"COMPLETED","sponsor":"Naurex, Inc, an affiliate of Allergan plc","startDate":"2016-10-15","conditions":"Depressive Disorder, Major","enrollment":465},{"nctId":"NCT03814733","phase":"PHASE1","title":"Assessment of Effect of Rapastinel on Driving Performance","status":"COMPLETED","sponsor":"Naurex, Inc, an affiliate of Allergan plc","startDate":"2018-11-05","conditions":"Driving Performance","enrollment":107}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo-matching Rapastinel","genericName":"Placebo-matching Rapastinel","companyName":"Naurex, Inc, an affiliate of Allergan plc","companyId":"naurex-inc-an-affiliate-of-allergan-plc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rapastinel is an NMDA receptor modulator that enhances glutamatergic neurotransmission by potentiating NMDA receptor function to improve cognitive and psychiatric symptoms. Used for Major depressive disorder (as adjunctive treatment), Cognitive impairment associated with schizophrenia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}